Stock Scorecard



Stock Summary for NovoCure Ltd (NVCR) - $14.53 as of 3/28/2024 8:08:50 AM EST

Total Score

8 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for NVCR

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for NVCR

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for NVCR

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for NVCR

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for NVCR

NovoCure ( NVCR ) Soars 12.0%: Is Further Upside Left in the Stock? 3/28/2024 9:01:00 AM
Eli Lilly, IBD Stock Of The Day, Jumps Entry As Obesity Space Heats 3/27/2024 4:22:00 PM
Why Is Novocure Stock Trading Higher On Wednesday? - NovoCure ( NASDAQ:NVCR ) 3/27/2024 2:16:00 PM
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday - Cintas ( NASDAQ:CTAS ) , Noah Holdings ( NYSE:NOAH ) , PaySign ( NASDAQ:PAYS ) 3/27/2024 2:03:00 PM
Medtech Stock Rockets After Wearable Device Outmaneuvers Cancer 3/27/2024 1:16:00 PM
Does NovoCure ( NVCR ) Have the Potential to Rally 63.51% as Wall Street Analysts Expect? 3/13/2024 1:55:00 PM
NovoCure ( NVCR ) Q4 2023 Earnings Call Transcript 2/22/2024 5:15:00 PM
NovoCure ( NVCR ) Reports Q4 Loss, Tops Revenue Estimates 2/22/2024 1:25:00 PM
Highlights From the 2024 JPMorgan Health Care Conference 1/22/2024 6:39:00 PM
Strength Seen in NovoCure ( NVCR ) : Can Its 16.8% Jump Turn into More Strength? 1/19/2024 12:46:00 PM

Financial Details for NVCR

Company Overview

Ticker NVCR
Company Name NovoCure Ltd
Country USA
Description NovoCure Limited, an oncology company, is engaged in the development, manufacture and marketing of Optune for the treatment of a variety of solid tumors. The company is headquartered in Saint Helier, Jersey.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/2/2024

Stock Price History

Last Day Price 14.53
Last Day Price Updated 3/28/2024 8:08:50 AM EST
Last Day Volume 11,920,571
Average Daily Volume 1,055,234
52-Week High 83.60
52-Week Low 10.87
Last Price to 52 Week Low 33.67%

Valuation Measures

Trailing PE N/A
Industry PE 50.34
Sector PE 60.76
5-Year Average PE -225.69
Free Cash Flow Ratio 1.71
Industry Free Cash Flow Ratio 67.97
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 5.78
Total Cash Per Share 8.50
Book Value Per Share Most Recent Quarter 3.38
Price to Book Ratio 3.90
Industry Price to Book Ratio 5.28
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 2.75
Industry Price to Sales Ratio Twelve Trailing Months 13.37
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 107,093,000
Market Capitalization 1,556,061,290
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -6.00%
Annual Earnings Growth -123.75%
Reported EPS 12 Trailing Months -1.95
Reported EPS Past Year -1.95
Reported EPS Prior Year -0.88
Net Income Twelve Trailing Months -207,043,000
Net Income Past Year -207,043,000
Net Income Prior Year -92,534,000
Quarterly Revenue Growth YOY 4.20%
5-Year Revenue Growth 15.47%

Balance Sheet

Total Cash Most Recent Quarter 910,616,000
Total Cash Past Year 910,616,000
Total Cash Prior Year 969,425,000
Net Cash Position Most Recent Quarter 341,794,000
Net Cash Position Past Year 341,794,000
Long Term Debt Past Year 568,822,000
Long Term Debt Prior Year 565,509,000
Total Debt Most Recent Quarter 568,822,000
Equity to Debt Ratio Past Year 0.39
Equity to Debt Ratio Most Recent Quarter 0.39
Total Stockholder Equity Past Year 362,496,000
Total Stockholder Equity Prior Year 441,170,000
Total Stockholder Equity Most Recent Quarter 362,496,000

Options

Put/Call Ratio 0.43
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.34
MACD Signal 0.02
20-Day Bollinger Lower Band 11.15
20-Day Bollinger Middle Band 13.96
20-Day Bollinger Upper Band 16.77
Beta 0.41
RSI 39.62
50-Day SMA 29.83
200-Day SMA 87.91

System

Modified 3/27/2024 2:53:03 AM EST